Operator
Welcome to the DBV Second Quarter 2026 Outcomes and Enterprise Replace Convention Name. [Operator Instructions] Please word, this occasion is being recorded. I might now like to show the convention over to Jonathan Neely, Investor Relations. Please go forward, sir.
Jonathan Neely
VP & Head of Investor Relations
Thanks. Good afternoon. DBV Applied sciences reported monetary outcomes for the second quarter and half 12 months of 2026. This replace is offered within the Press Releases part of the DBV Applied sciences web site.
Earlier than we start, please word that immediately’s name could embody a variety of forward-looking statements, together with, however not restricted to, feedback concerning our forecast of estimated money runway, scientific and regulatory improvement plans, the design and conduct of our scientific trials, the timing and the outcomes of interactions with regulatory businesses and the power of any of our product candidates, if permitted, to enhance the lives of sufferers with meals allergy symptoms. These forward-looking statements are based mostly on assumptions which might be topic to dangers and uncertainties that would trigger the corporate’s precise outcomes to vary considerably from these steered by these statements.
Given these dangers and uncertainties, you shouldn’t place undue reliance on these forward-looking statements. Please consult with the corporate’s filings with the SEC and the French AMF for data regarding threat elements that would trigger the corporate’s precise outcomes to vary
